Overview

VELCADE,Rituximab,Cyclophosphamide and Decadron

Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Overall response rate and Time to disease progression using this regimen in patients with low-grade B-Cell Non-Hodgkin's Lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Oncology Specialists, S.C.
Collaborator:
Millennium Pharmaceuticals, Inc.
Treatments:
BB 1101
Bortezomib
Cyclophosphamide
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Rituximab